Correlation Between Corvus Pharmaceuticals and Leap Therapeutics
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Leap Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Leap Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Leap Therapeutics, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Leap Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Leap Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Leap Therapeutics.
Diversification Opportunities for Corvus Pharmaceuticals and Leap Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Corvus and Leap is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Leap Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Leap Therapeutics and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Leap Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Leap Therapeutics has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Leap Therapeutics go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Leap Therapeutics
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.63 times more return on investment than Leap Therapeutics. However, Corvus Pharmaceuticals is 1.59 times less risky than Leap Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Leap Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 756.00 in Corvus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 138.00 from holding Corvus Pharmaceuticals or generate 18.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. Leap Therapeutics
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| Leap Therapeutics |
Corvus Pharmaceuticals and Leap Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and Leap Therapeutics
The main advantage of trading using opposite Corvus Pharmaceuticals and Leap Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Leap Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leap Therapeutics will offset losses from the drop in Leap Therapeutics' long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |